“SMC’s A2LA accreditation for our suite of COVID-19 services is yet another example of our company’s innovative approach to pathogen and molecular source tracking.” – Anda Quintero, SMC’s Laboratory Scientific Director

FREDERICK, Md. (PRWEB)
June 25, 2020

On May 21st, the A2LA-accredited laboratory Source Molecular Corporation (SMC) introduced testing services for SARS-CoV-2, the virus that causes COVID-19, on wastewater, air, and surfaces. They are the first A2LA-accredited laboratory to conduct this type of SARS-CoV-2 testing, which is covered by their flexible scope of accreditation. SMC, a Florida-based molecular testing lab, provides innovative technology to help solve pathogenic water, air and surface pollution problems through source tracking, genetic and molecular techniques, and test kits. These new tests, developed to help address the spread of coronavirus, are a timely complement to their longstanding mission. A2LA updated SMC’s scope in 2019 when their accreditation was renewed, which enabled them to add these new tests in response to the ongoing global pandemic.

By providing a suite of commercial COVID-19 environmental testing supplies and services, SMC assists clients with identification, data interpretation, solution strategies and continued virus monitoring for private and public sectors including hospitality, travel, agriculture, medical services, utilities, wastewater and large government agencies. SMC has been accredited by A2LA since 2017 and throughout the years their in-house laboratory has analyzed samples for hundreds of industrial plants, watershed management groups, government agencies, universities, and engineering firms. SMC is one of the global leaders in both Pathogenic Source Tracking (PST) and Microbial Source Tracking (MST). With a broad range of new tests and testing methods being developed in response to COVID-19, third-party accreditation by A2LA helps to ensure that the organizations developing these tests are competent and that their test results are produced with reliable and consistent methods.

“SMC’s A2LA accreditation for our suite of COVID-19 services is yet another example of our company’s innovative approach to pathogen and molecular source tracking.” Says Anda Quintero, SMC’s Laboratory Scientific Director. “From the beginning, accreditation by A2LA to ISO 17025:2005 helped us build a strong foundation for our top-quality services in the MST field. We updated our fixed scope to flexible scope last year to ISO 17025:2017 during our renewal of accreditation. The flexible scope allows us to take swift steps to respond to public health emergencies, such as COVID-19 environmental testing, in a way that we can best serve our clients in the time they most needed, without sacrificing the quality of our work. Therefore, we are always grateful to work with A2LA.”

About Source Molecular Corporation

Source Molecular is a US-based provider of molecular testing, pathogenic source tracking, microbial source tracking, and related consultation services founded in 2002. To learn more about them visit sourcemolecular.com.

About A2LA

A2LA is a non-profit, non-governmental, third-party accreditation body, offering internationally recognized accreditation services to testing and calibration laboratories, sampling organizations, inspection bodies, proficiency testing providers, reference material producers, biobanking facilities, and product certifiers. To learn more, visit A2LA.org.

Share article on social media or email:

Xtalks Life Science Webinars

Spectral imaging microscopy and deep-learning-based image analysis was applied and found to be a powerful tool that enables in situ analysis of macrophage phenotypes and other cells in human liver biopsies and may lead to more personalized therapeutic approaches in the future.

TORONTO (PRWEB)
June 25, 2020

Join Heather Stevenson, MD, PhD, Associate Professor, Dept. of Pathology and Director of Transplantation Pathology at The University of Texas Medical Branch in a live session on Tuesday, July 14, 2020 at 11am EDT (4pm BST/UK).

Intrahepatic macrophages influence the composition of the microenvironment, host immune response to liver injury and development of fibrosis. Using a multiplex protocol, Dr. Stevenson’s group stained biopsies collected from representative patients with chronic liver diseases, including chronic hepatitis C, non-alcoholic steatohepatitis and autoimmune hepatitis. Spectral imaging microscopy and deep-learning-based image analysis was applied and found to be a powerful tool that enables in situ analysis of macrophage phenotypes and other cells in human liver biopsies and may lead to more personalized therapeutic approaches in the future.

In the webinar, Dr. Stevenson will present her group’s findings from an analysis of five different antibodies commonly observed on macrophage populations (CD68, MAC387, CD163, CD14 and CD16).

For more information or to register for this event, visit How Multispectral Imaging Enables Analysis of Macrophages in Chronic Liver Disease.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

“We are pleased to recognize Dr. Tarek Pacha as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson

PLEASANTON, Calif. (PRWEB)
June 25, 2020

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Tarek Pacha, D.O., Memorial Heathcare in Owosso, MI, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Pacha has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are pleased to recognize Dr. Tarek Pacha as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “This achievement has helped many patients experience durable, long- term relief from the burdensome symptoms of BPH while preserving sexual function*1,2.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Sharon Kleyne, Founder of Bio Logic Aqua® Research

GRANTS PASS, Ore. (PRWEB)
June 25, 2020

Air Date: 22 June 2020

Guests: Dr. Philip Paden, M.D., Ophthalmologist, Medford, Oregon

https://www.voiceamerica.com/episode/124183/immunity-protector-with-natures-tears-eyemist

“Eyes are our number one sensory input,” says Philip Paden, M.D., on Sharon Kleyne Talk Radio VoiceAmerica World Talk Radio & Apple iTunes. “Being able to see clearly is being able to receive information you need to proceed with life.” Paden recommends Nature’s Tears® EyeMist® to patients for immunity strengthening protection of the eyes.

Paden began his professional life teaching chemistry for ten years at Cornell University. After graduating from the Albert Einstein College of Medicine if Yeshiva University in 1982 and serving his internship in Portland, Oregon, Paden has practiced ophthalmology in Medford, Oregon where he says the number one complaint he hears from patients is “uncomfortable eyes. If your eyes are uncomfortable,” says Paden, “you are unhappy and not performing at your best.”

In her commentary, internationally respected water technology researcher and host Kleyne, who is also founder of Bio Logic Aqua® Research Water Life Science®, declares that “water is the primary life of earth” and that we all live with the water vapor in the atmosphere. Kleyne also points out that “dry eye is over-evaporation of the eye’s tear film. There are no two eyes alike, no two fingerprints alike and no two skins alike.”

Kleyne teaches immunity strengthening and protection education and also that there is only one dry eye product in the world, Nature’s Tears® EyeMist®, that is 100 percent Trade Secret water and naturally pH balanced without formulating it. “The pH balance is what gives the immunity strengthening protection to the eye.” Noting that Paden is one of the authors of her educational animation of the tear film, which shocked so many viewers, Kleyne asks him to teach the audience about the tear film.

“The surface of the eye,” Paden begins, “is the tear film. The number one role of the tear film is to fill the microscopic bumps in the cornea to give you an optical surface that allows very precise vision. The tear film,” Paden continues, “requires three layers in order to stay on the cornea and not run down and off the eye. There’s a mucous layer on top of that, and an aqueous layer that is almost 100 percent water.”

Paden also teaches that “there is an extremely thin surface on the tear film which consists of a single layer of lipids or fats. It is there to slow down evaporation. This area,” adds Paden, “is full of microorganisms. The tear film is actually an army of antibody molecules. If the eye dehydrates, the antibody molecules don’t work as well. Nature’s Tears® EyeMist® is the only tear supplement that is pure water delivered to the eye as a micron-size mist.” Paden says that other dry eye products flood the eye, washing away the molecular antibodies needed for immunity strengthening protection. When Kleyne asks about the actual size of a micron, Paden explains that a micron is a millionth of a meter, much less than a millimeter.

“Nature’s Tears® EyeMist®,” says Paden, “returns the tear film to its normal osmolarity and thickness. Not a single dry eye product on the planet, other than Nature’s Tears® EyeMist®, restores the tear film.”

LISTEN to the internationally syndicated The Power of Water® & Your Health sponsored by Nature’s Tears® EyeMist®, naturally pH balanced water technology for acid mantel protection, on VoiceAmerica World Talk Radio & Apple iTunes with producer and host Sharon Kleyne and program director Rose Hong of Global Dragon TV. This program features ophthalmologist Philip Paden, M.D.

Follow this link: https://www.voiceamerica.com/episode/124183/immunity-protector-with-natures-tears-eyemist

Some recent programs feature:

Kevin Kearns & Steven Aithwaite

https://www.voiceamerica.com/episode/124035/earths-human-mission-a-healthier-planet

Mary Carolyn, Nutritionist https://www.voiceamerica.com/episode/123934/natural-immune-boosters

Kevin Kearns & Brandon Foster https://www.voiceamerica.com/episode/123823/strengthening-childrens-immune-system-through-fitness

Dr. Gerald Pollack, Ph.D. https://www.voiceamerica.com/episode/123059/the-fourth-phase-of-water

Kevin Kearns & Diana Healy https://www.voiceamerica.com/episode/123560/how-to-stay-active-during-the-pandemiclockdown

Dr. Gerald Pollack, Ph.D. https://www.voiceamerica.com/episode/123059/the-fourth-phase-of-water

If you would like to watch a brief, entertaining educational film that demonstrates the application of the new Dry Eye Solution® technology Nature’s Tears® EyeMist®, sponsor of Sharon Kleyne’s talk radio program, go here: https://www.youtube.com/watch?v=l0gOr8TB45U

Share article on social media or email:

Laura Kreofsky, Advisory VP, leads Pivot Point Consulting telehealth services

Success in today’s fast-moving telehealth market requires a blend of competitive and environmental intelligence, technology, workflow and revenue cycle readiness and intentional focus on the patient experience.

NASHVILLE, Tenn. (PRWEB)
June 25, 2020

Pivot Point Consulting, a national healthcare IT consulting leader and the 2020 Best in KLAS Overall IT Services Firm, expanded its telehealth services to provide end-to-end solutions from strategy to platform selection to implementation.

Led by seasoned telehealth expert and a Consulting Magazine “2020 Women Leaders in Technology” award winner, Laura Kreofsky, Advisory VP, Pivot Point Consulting’s telehealth specialists help healthcare providers strategically grow virtual care programs and optimize telehealth platforms. They bring focused expertise in telehealth regulations, experience in platform, device and third-party application selecting, implementation and optimization and best practices in telehealth support.

“Success in today’s fast-moving telehealth market requires a blend of competitive and environmental intelligence, technology, workflow and revenue cycle readiness and intentional focus on the patient experience,” says Kreofsky.

“Whether you’re new to telehealth or if you have telehealth services to take to the next level, we bring market insights and best practices, disciplined methodology and specialists experienced in setting and executing on strategic telehealth goals.”

As part of the telehealth service portfolio, Pivot Point Consulting continues to provide pro bono assistance to providers and healthcare organizations on the FCC COVID-19 telehealth funding program and offer complimentary telehealth strategy workshops to provider organizations.

“We have always invested in telehealth, but now we’re doubling down to keep pace with the needs of today’s rapidly changing market,” says Rachel Marano, Co-Founder and Managing Partner.

About Pivot Point Consulting

Pivot Point Consulting, 2020 Best in KLAS: Overall IT Services Firm, enables healthcare organizations to realize the most value from their technology and data through our Advisory, Implementation, Optimization, Managed Services and Talent Solutions. We work with provider and payer organizations and have 450+ employees serving over 100 clients across the U.S. Pivot Point Consulting has earned many industry and workplace quality awards including: 

Best in KLAS: Overall IT Services Firm (2020) , Top Three Best in KLAS for HIT Implementation and Support (2015, 2016, 2017, 2018, 2019) , Highest Rated Vendor in KLAS Implementation Services in the Select Category (2017) , #1 in KLAS for Epic Consulting in the Select Category (2016) , #9 in Modern Healthcare’s Best Places to Work (2016)  

Practices: Epic®, Community Connect®, Cerner®, Siemens®, Allscripts®, MEDITECH®, McKesson®, Centricity®, eClinicalWorks®, NextGen® CPSI®, MEDHOST®, athenahealth®, Greenway®, Workday®, Lawson/Infor®, Peoplesoft®, SAP®, Kronos® and Facets®.  

For more information, visit us at pivotpointconsulting.com.

Share article on social media or email: